Latest Cardiomyopathies
REPLACE COVID Trial: Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers Can Be Safely Continued in Patients Admitted to Hospital With COVID-19
A recent trial by Dr. Jordana B Cohen, published in The LANCET, indicated that…
EMPEROR-Reduced Trial: Empagliflozin Use Was Associated With a Better Clinical Outcomes Among Patients With Heart Failure and a Reduced Ejection Fraction
A recent study by Dr. Milton Packer, published in Circulation, demonstrated that…
Cohort Study Showed a Large Number of Patients Receiving Anticancer Therapy Demonstrate Myocardial Injury or Left Ventricular Dysfunction, With Only Few Showing Severe Cardiotoxicity
A recent study by Dr. Lopez-Sendon, published in European Heart Journal, showed…
Study Shows Hepatitis C Status Not Associated With Adverse Events in Adult Heart Transplant Patients by 1 Year
A recent study by Dr. Kilic, published in the American Heart Association…
Elevated Coronary Sinus Neuropeptide Y Levels Are Associated With Adverse Outcomes in Patients With Chronic Heart Failure
The study by Dr. Ajijola, published in JAMA Cardiology, found that elevated…
The Sarcomeric Human Cardiomyopathy Registry: Race Associated with Disease Expression and Clinical Outcomes Among Patients with Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy (HCM) is the most common inherited genetic disorder of the…
Cardiogenic Shock in Takotsubo Syndrome: Incidence, Predictors, and Outcomes
Cardiogenic shock (CS) is not a rare complication in patients with Takotsubo…
Tafamidis, A Real Hope for People with Transthyretin Cardiomyopathy?
On Thursday, March 29th, Pfizer announced positive topline results from ATTR-ACT trial…